Poster Discussion Round:
126. HIV
Friday, October 4, 2013: 12:30 PM-2:00 PM
Room: The Moscone Center: Poster Hall C

Learning Objectives:

Sessions on new, unpublished information presented as posters in the areas of HIV medicine, antimicrobials, bacterial diseases, fungal diseases, public health, pediatric infectious diseases, virology, and vaccines will be critiqued by experts in each of these fields.  It is assumed that participants know or are familiar with the general principles of the epidemiology, pathogenesis, prevention, and therapy of infectious diseases.  At the completion of the session, participants will have gained knowledge on emerging information in infectious diseases with the ability to place this information in the context of prior published data.

Target Audience: academicians, clinicians, epidemiologists, fellows, health care workers, HIV clinicians, HIV specialists, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, public health practitioners, researchers, scientists, vaccinologists

Tracks: HIV-STD-TB

Group Leader:  Kathleen Squires, MD, Thomas Jefferson University

Presentations:

12:30 PM
Group Leader
Kathleen Squires, MD

CME Credits:

ACPE Credits:

ACPE Number:

Disclosures:

K. Squires, Biocryst: Investigator, Research grant
Gilead Sciences: Investigator and Scientific Advisor, Honoraria and Research grant
Merck: Scientific Advisor, Consulting fee and Honoraria
Vertex: Investigator, Research grant
Janssen: Scientific Advisor, Honoraria
Tobira: Scientific Advisor, Honoraria
Viiv: Scientific Advisor, Honoraria

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.